A post-translational regulatory map of chronic antigen-driven human T cell dysfunction
Authors:
- Hiroyuki KojimaHKHiroyuki Kojima
- Charlotte R. WayneCWCharlotte R. Wayne
- Luis F. Somarribas PattersonLPLuis F. Somarribas Patterson
- Henry SanfordHSHenry Sanford
- Tzu-Jou ChenTCTzu-Jou Chen
- Ya-Hui LinYLYa-Hui Lin
- Joshua D. SchoenfeldJSJoshua D. Schoenfeld
- Lisa H. F. McGaryLMLisa H. F. McGary
- Yan-Ting ChenYCYan-Ting Chen
- Korbinian N. KroppKKKorbinian N. Kropp
- Beatrice ZhangBZBeatrice Zhang
- Jahan RahmanJRJahan Rahman
Preprint
Abstract
SUMMARY: T cells exposed to persistent antigen in the context of chronic viral infections or cancer lose self-renewal and cytotoxic capacity. Several transcriptional, epigenetic, and metabolic drivers of this process have been identified. However, the post-transcriptional regulatory mechanisms influencing the proteome of dysfunctional T cells are not well understood. Here we present a time-resolved molecular landscape of human T cells during the development of chronic antigen-driven dysfunction. Persistent T cell receptor stimulation significantly remodeled the proteome, including changes in canonical T cell exhaustion-associated proteins and proteins related to mitochondrial function, redox homeostasis, nucleotide metabolism, and cell-cycle progression. Dysfunctional T cells displayed activation of stress response pathways that were recapitulated in vivo ; targeting these pathways altered the cytotoxic capacity of T cells during persistent tumor exposure. Our comprehensive proteomic resource reveals unique post-transcriptional changes in dysfunctional T cells and lays the groundwork for novel cysteine-directed therapeutics to enhance cancer immunotherapy.Keywords
Funding Information
- Neil S. Hirsch Foundation
- Break Through Cancer
- NIH/NCI (R01 CA251138)
- NIH/NCI (R01 CA242020)
- NIH/NCI (R01 CA283364)
- NIH/NCI (P50 CA254838)
- NIH/NCI (K08 CA237731)
- NIH/NHLBI (R01 HL128239)
- The Leukemia & Lymphoma Society
- Cancer Center Support Grant (P30 CA008748)
- NIH/NIGMS (T32GM152349)
- NIH/NIGMS (T32GM136640-Tan)
- Herbert and Nell Singer Foundation
- The Alexandrine and Alexander L. Sinsheimer Fund
- Weill Cancer Hub East
- The Stavros Niarchos Foundation Institute for Global Infectious Disease Research at Rockefeller
- CZ Biohub New York Investigator Program
- Pels Family Center
- Marlene Hess Center for Research on Women’s Health and Biomedicine
- Memorial Sloan-Kettering Cancer Center (MERIT Mandel Postdoctoral Fellowship)
- Memorial Sloan-Kettering Cancer Center (MSK Society Scholars Prize)
- Memorial Sloan-Kettering Cancer Center (Basic and Translational Immunology Postdoctoral award from the Ludwig Center)
- Memorial Sloan-Kettering Cancer Center (Center for Experimental Immuno-Oncology)
- Deutsche Forschungsgemeinschaft
- Melanoma Research Foundation
- NIH (R37 CA259177)
- NIH (R01 CA286507)
- NIH (P50 CA217694)
- NIH (P30 CA008748)
- Cycle for Survival
- the Metropoulos Family Foundation
- the Samuel I. Newhouse Foundation
- The Castellano Family
- the Weiss Family Kidney Research Fund
- NCI Cancer Center Support Grant (P30 CA08748)
This publication has 157 references indexed in Scilit:
- Complex heatmap visualizationiMeta, 2022
- Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceCancer Cell, 2022
- Tumor suppressor p53: Biology, signaling pathways, and therapeutic targetingBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacyCancer Cell, 2021
- Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesCancer Cell, 2020
- Nucleosome assembly proteins NAP1L1 and NAP1L4 modulate p53 acetylation to regulate cell fateBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2019
- Data Analysis2016
- Activity-Based Imaging Probes of the ProteasomeCell Biochemistry and Biophysics, 2013
- Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition stateBiochemical and Biophysical Research Communications, 2010
- ATP citrate lyase inhibition can suppress tumor cell growthCancer Cell, 2005